Trial
NCT04595981
Chemo-embolization for Head and Neck Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
SCCHN
Intervention
Cisplatin
Why stopped
No staff or funding to do the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-27